Chemical Pathology Flashcards

1
Q

Rise in Troponin is specific to heart but not specific to cause

A

Non MI myocardial injury:
- myocarditis

Multifactorial myocardial injury:
- pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Serial measurement of cardiac Troponin

A

0, 3, 6 hours
If initial levels negative —> additional measurements
Still negative —> exclude AMI

Rise is bigger in MI than myocarditis
Chronic heart failure —> no rise/fall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Definition of MI

A
  • Cardiac markers + symptoms / ECG/ imaging/ intracoronary thrombus
  • at least one cardiac marker > 99th percentile of upper reference limit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

5 types of MI

A

Type 1: secondary to plaque
Type 2: not due to ACS (coronary spasm, embolism)
Type 3: sudden cardiac death (no biomarker)
Type 4: procedure related (PCI)
Type 5: coronary artery bypass grafting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Approach to cardiac marker abnormality

A
  • Test validity
  • level and trend
  • relationship too symptom
  • exclude non-AMI cause
  • consider AMI cause
  • acute / long term treatment
  • monitoring
Rising may not duet to AMI
Late presentation of MI may not appear to be changing (near peak / gradual down)
Analytical interference (use other instrument)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 major natriuretic peptide

A

ANP (from atria):
—> response to pressure / volume overload —> natriuresis, oppose RAAS

BNP (from ventricle):
—> response to cardiac wall stretch —> natriuresis, reduce preload
—> BNP + NTproBNP (byproduct)
—> diagnose ***heart failure who present acutely with dyspnea
—> identify cardiac involvement
—> prognostic marker in HF, ACS (high BNP —> poorer prognosis)
—> monitor drug therapy

CNP (vascular endothelium):
—> regulate vascular tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Criteria for valid Therapeutic Drug Monitoring (TDM)

A
  1. Poor correlation between dose and effect
  2. Narrow therapeutic window
  3. Absence of good clinical marker of effect
  4. Good correlation between plasma concentration and effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drugs need TDM

A

Digoxin

  • 2 compartment
  • high volume of distribution —> distribute mainly in tissue
  • blood concentration correlate with effect after 6-8 hours
  • collection time (minimum 8 hours, prefer 12 hours)
  • renal excreted
  • 0.5-2.0 ng/mL (critical value: 2.5)
  • toxicity: arrhythmia, nausea, vomiting
  • **- hypokalaemia, hypomagnesemia, hypercalcemia, impaired renal function enhance toxicity
  • activated charcoal, Digibind (Digoxin-specific antibody), haemodialysis not effective since distribute in tissue
  • immunoassays may not be accurate: Interference: Digoxin-like immunoreactive substance (DLIS), Megdigoxin, steroid, Spironolactone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pharmacogenetics of Clopidogrel

A
  • pro-drug —> convetered to active metabolite (inhibit ADP P2Y12 and plate activation)
  • 2C19:
    *1 —> wild type
    *2 —> no activity
    3 —> no activity
    (
    2 and *3 account for almost all poor metabolisers in Asian)
  • 2 defective copies of allele may not achieve therapeutic effect
    —> increase dose / switch to other drugs
  • 1 defective copy —> increase dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Urine analysis

A
  1. Macroscopic:
    - colour: red —> haemoglobin, myoglobin, drugs, food
    - turbidity
    - volume
  2. Microscopic:
    - casts (ligh chains)
    - crystals
    - bacterial staining / cultrue
    - chyle (lymph due to inflammation of glomerulus)
  3. Chemical analysis (urine dipstick)
    - limitations: pathologic vs non-pathologic cause of abnormal urine dipstick
    - false-positive vs false-negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Urine pregnancy test

A

Lower limit of detection (high sensitivity)

Urine hCG: 25 mIU/mL

Blood hCG:

  • Non-pregnant: <5
  • 0.2-1 week: 5-50 mIU/L
  • Every week increase 10x

False positive:

  • early miscarriage
  • missed reaction time (sit for too long —> do not wait till +ve)
  • drugs: hCG shot for infertility treatment
  • faint evaporation line
  • abuse of drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Urine sample collection

A
  • spot
  • timed (24 hour: first void in morning discarded, subsequent collect every void)
  • midstream
  • Creatinine clearance
  • 24 hour urine collection CrCl:
    urine creatinine x urine volume / plasma creatinine x time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cerebrospinal fluid

A
  • from Choroid plexus
  • clear fluid with NO cells
  • precious sample
  • procedure for CSF collection
    1. Four tubes under aseptic technique (needle into spine)
    2. Each tube 2-4ml
    3. Send promptly within 1 hour
    4. Do not refrigerate

Analysis:

  • colour/ appearance: blood, turbidity, xanthochromia
  • open pressure measurement
  • chemical analysis (lactate)
  • immunological (antibodies)
  • anatomical pathology (cytology)
  • high protein —> life-threatening —> protein leak through BBB
  • low glucose —> consumed by bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pleural fluid

A
  • 30ml normally

Chemical analysis:

  • pH
  • LDH
  • protein
  • TAG (chylothorax)

Transudate = total protein < 30g/L

  • **Exudate: (1 of 3 criteria)
  • pleural fluid:serum total protein > 0.5
  • pleural fluid:serum LDH > 0.6
  • pleural fluid LDH > 2/3 upper normal limit of LDH

Pleural adenosine deaminases (ADA) activity: good test

  • Tuberculosis: high
  • Empyema: low
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Factors affecting result interpretation

A
  1. Pre-analytical
    - patients factors (correct patients, age, gender, diet, drugs)
    - sampling factors (storage time, sampling time, specimen type)
  2. Analytical
    - correct test on correct specimen
    - performance of test (accuracy, imprecision, sensitivity, specificity)
  3. Post-analytical
    - transcription, computer data uploading
    - appropriate reference interval
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Reference interval

A
  • **Reference interval: represent central 95% of reference individuals
  • Values derived from distribution of results obtained from reference population (healthy individuals)
  • usually 2 values (upper and lower reference limit)

Reference individuals —> population —> sample group —> values —> distribution —> limits —> intervals

  • Parametric: Mean +/- 2 SD (95.4% within 2SD, assume Gaussian distribution)
  • Non-parametric: 2.5th and 97.5 percentile (95% included, no assumption of distribution)
17
Q

Blood analyses requiring partitioning of reference intervals

A

Age: Growth hormone
Gender: Testosterone, oestrogen
Posture: Renin, aldosterone
Diet: glucose, TAG

18
Q

Inter vs Intra-individual variation

A

Intra:
- biological variation: e.g. progesterone level
Inter:
- between individuals

Narrow intra-individual variation —> inter-individual less sensitive than intra-individual variation (睇inter-individual無意思, 睇intra-individual先有用)

19
Q

Clinical decision limits

A
  • **- dividing lines between normal and diseased
  • **- consensus value / predictive value
  • usually one value, without confidence interval
  • may change with time (reference intervals will not)
  • can be distinct from reference limits
  • useful for integrating test results for diagnosis and clinical management
  1. Bayesian approach (e.g. Troponin) —> based on:
    - definition
    - pathogenesis
    - sensitivity of test
    - specificity of test
    - prevalence
    - clinical costs for misclassification
  2. Epidemiological approach (e.g. cholesterol, glucose) —> based on:
    - population studies
    - national guidelines / consensus
    - outcomes studies showing different level of survival with concentrations above or below limit
  3. Pathophysiological approach —> based on:
    - critical values —> life threatening situation
    - arbitrary
    - clinical experience
    - without support of statistical mean
20
Q

Positive predictive value, Negative predictive value, Sensitivity, Specificity

A

PPV = True positive / All positive
NPV = True negative / All negative
Sensitivity = True positive / All disease —> ability to pick up all diseased people
—> high sensitivity —> high NPV (very few false negative)
Specificity = True negative / All healthy —> ability to exclude normal people
—> high specificity —> high PPV (very few false positive)

21
Q

Likelihood ratio

A

LR+ = P(+ve test in diseased) / P(+ve test in normal people)
—> Sensitivity / 1-Specificity

LR- = P(-ve test in diseased) / P(-ve test in normal people)
—> 1-Sensitivity / Specificity

22
Q

Receiver Operating Characteristic Curve (ROC)

A

Performance of 2 different tests can be compared
—> by plotting sensitivity against (1-specificity)

  1. Better the test curve lies above and left
  2. Larger AUC